183 related articles for article (PubMed ID: 20050670)
1. Rational design of targeted cancer therapeutics through the multiconjugation of folate and cleavable siRNA to RAFT-synthesized (HPMA-s-APMA) copolymers.
York AW; Huang F; McCormick CL
Biomacromolecules; 2010 Feb; 11(2):505-14. PubMed ID: 20050670
[TBL] [Abstract][Full Text] [Related]
2. Facile synthesis of multivalent folate-block copolymer conjugates via aqueous RAFT polymerization: targeted delivery of siRNA and subsequent gene suppression.
York AW; Zhang Y; Holley AC; Guo Y; Huang F; McCormick CL
Biomacromolecules; 2009 Apr; 10(4):936-43. PubMed ID: 19290625
[TBL] [Abstract][Full Text] [Related]
3. Galactosylated 2-hydroxypropyl methacrylamide-s-3-guanidinopropyl methacrylamide copolymer as a small hairpin RNA carrier for inhibiting human telomerase reverse transcriptase expression.
Wu Y; Ji J; Yang R; Zhang X; Li Y; Pu Y; Li X
J Gene Med; 2014; 16(5-6):109-21. PubMed ID: 24981025
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
Qin Z; Liu W; Li L; Guo L; Yao C; Li X
Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
[TBL] [Abstract][Full Text] [Related]
5. Conjugates of HA2 with octaarginine-grafted HPMA copolymer offer effective siRNA delivery and gene silencing in cancer cells.
Golan M; Feinshtein V; David A
Eur J Pharm Biopharm; 2016 Dec; 109():103-112. PubMed ID: 27702685
[TBL] [Abstract][Full Text] [Related]
6. Guanidinylated 3-gluconamidopropyl methacrylamide-s-3-aminopropyl methacrylamide copolymer as siRNA carriers for inhibiting human telomerase reverse transcriptase expression.
Wu Y; Ji J; Yang R; Zhang X; Li Y; Pu Y; Li X
Drug Deliv; 2013; 20(7):296-305. PubMed ID: 24044647
[TBL] [Abstract][Full Text] [Related]
7. Neutral polymeric micelles for RNA delivery.
Lundy BB; Convertine A; Miteva M; Stayton PS
Bioconjug Chem; 2013 Mar; 24(3):398-407. PubMed ID: 23360541
[TBL] [Abstract][Full Text] [Related]
8. Multivalent methionine-functionalized biocompatible block copolymers for targeted small interfering RNA delivery and subsequent reversal effect on adriamycin resistance in human breast cancer cell line MCF-7/ADR.
Wu Y; Zhang W; Li T; Ma R; Chen D; Zhang J; Wu J; Tang J
J Gene Med; 2017 Aug; 19(8):. PubMed ID: 28688213
[TBL] [Abstract][Full Text] [Related]
9. Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation.
Manhas P; Cokca C; Sharma R; Peneva K; Wangoo N; Sharma D; Sharma RK
Int J Biol Macromol; 2024 Feb; 259(Pt 2):129242. PubMed ID: 38199540
[TBL] [Abstract][Full Text] [Related]
10. Well-Defined Cationic N-[3-(Dimethylamino)propyl]methacrylamide Hydrochloride-Based (Co)polymers for siRNA Delivery.
Singhsa P; Diaz-Dussan D; Manuspiya H; Narain R
Biomacromolecules; 2018 Jan; 19(1):209-221. PubMed ID: 29195038
[TBL] [Abstract][Full Text] [Related]
11. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA.
Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576
[TBL] [Abstract][Full Text] [Related]
12. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
Pike DB; Ghandehari H
Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
[TBL] [Abstract][Full Text] [Related]
13. The guanidinium group as a key part of water-soluble polymer carriers for siRNA complexation and protection against degradation.
Tabujew I; Freidel C; Krieg B; Helm M; Koynov K; Müllen K; Peneva K
Macromol Rapid Commun; 2014 Jul; 35(13):1191-7. PubMed ID: 24700561
[TBL] [Abstract][Full Text] [Related]
14. Studies on guanidinated N-3-aminopropyl methacrylamide-N-2-hydroxypropyl methacrylamide co-polymers as gene delivery carrier.
Qin Z; Liu W; Guo L; Li X
J Biomater Sci Polym Ed; 2012; 23(1-4):133-52. PubMed ID: 22133350
[TBL] [Abstract][Full Text] [Related]
15. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
Ding H; Kopecková P; Kopecek J
J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
[TBL] [Abstract][Full Text] [Related]
16. Endolytic, pH-responsive HPMA-b-(L-Glu) copolymers synthesized via sequential aqueous RAFT and ring-opening polymerizations.
Holley AC; Ray JG; Wan W; Savin DA; McCormick CL
Biomacromolecules; 2013 Oct; 14(10):3793-9. PubMed ID: 24044682
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of folate-functionalized RAFT polymers for targeted siRNA delivery.
Benoit DS; Srinivasan S; Shubin AD; Stayton PS
Biomacromolecules; 2011 Jul; 12(7):2708-14. PubMed ID: 21634800
[TBL] [Abstract][Full Text] [Related]
18. Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization.
Randárová E; Nakamura H; Islam R; Studenovský M; Mamoru H; Fang J; Chytil P; Etrych T
Acta Biomater; 2020 Apr; 106():256-266. PubMed ID: 32058082
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers.
Ríhová B; Kubácková K
Curr Pharm Biotechnol; 2003 Oct; 4(5):311-22. PubMed ID: 14529421
[TBL] [Abstract][Full Text] [Related]
20. RAFT-derived polymer-drug conjugates: poly(hydroxypropyl methacrylamide) (HPMA)-7-ethyl-10-hydroxycamptothecin (SN-38) conjugates.
Williams CC; Thang SH; Hantke T; Vogel U; Seeberger PH; Tsanaktsidis J; Lepenies B
ChemMedChem; 2012 Feb; 7(2):281-91. PubMed ID: 22144261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
